Valuation: Becton, Dickinson and Company

Market Cap 42.76B 37.43B 34.55B 32.23B 60.73B 4,043B 61.81B 414B 161B 1,995B 161B 157B 6,951B P/E 2026 *
38.7x
P/E 2027 * 29.8x
Enterprise Value 58.72B 51.39B 47.44B 44.25B 83.38B 5,552B 84.87B 569B 221B 2,740B 221B 216B 9,544B EV / Sales 2026 *
3.06x
EV / Sales 2027 * 2.88x
Free-Float
74.04%
Yield 2026 *
2.48%
Yield 2027 * 2.52%
1 day-2.49%
1 week+5.15%
Current month+2.86%
1 month+4.13%
3 months-2.17%
6 months-22.65%
Current year-22.02%
1 week 144.61
Extreme 144.61
156.89
1 month 140.11
Extreme 140.11
156.89
Current year 140.11
Extreme 140.11
213.08
1 year 140.11
Extreme 140.11
213.08
3 years 140.11
Extreme 140.11
287.32
5 years 140.11
Extreme 140.11
287.32
10 years 140.11
Extreme 140.11
287.32
Manager TitleAgeSince
Chief Executive Officer 53 28/01/2020
Director of Finance/CFO 44 05/12/2025
Compliance Officer - 01/02/2023
Director TitleAgeSince
Director/Board Member 75 24/09/2002
Director/Board Member 71 26/07/2010
Chairman 53 28/04/2021
Date Insider Type Main position Quantity % Market Cap.
26/06Sell

Executive/Senior Manager

-75 0.0000%
24/06Sell

Executive/Senior Manager

-1,100 0.0004%
22/06Other

EVP and Chief People Officer

39,984 0.0145%
Change 5-day change 1-year change 3-year change Capi.($)
-2.49%+5.15%-12.15%-42.68% 42.76B
-2.12%+0.23%-33.28%-16.77% 161B
-3.34%-2.98%-10.26%-11.20% 104B
+0.47%+0.67%-5.63%+47.06% 54.8B
+0.56%-3.80%+53.05%+53.64% 53.31B
-0.43%+11.73% - - 33.49B
-3.76%-2.28%-22.84%-47.59% 27B
+1.22%+6.72%+64.08%-6.14% 25.06B
-1.25%+3.62%-12.34%-6.41% 20.78B
-0.58%-0.47%-17.49%-3.52% 20.47B
Average -0.95%+4.78%+0.35%-3.73% 54.27B
Weighted average by Cap. -0.97%+4.48%-7.98%-3.73%

Financials

2026 *2027 *
Net sales 19.21B 16.81B 15.52B 14.47B 27.27B 1,816B 27.76B 186B 72.26B 896B 72.15B 70.54B 3,122B 19.71B 17.25B 15.93B 14.86B 27.99B 1,864B 28.49B 191B 74.16B 920B 74.05B 72.4B 3,204B
Net income 1.12B 984M 909M 848M 1.6B 106B 1.63B 10.9B 4.23B 52.47B 4.23B 4.13B 183B 1.45B 1.27B 1.17B 1.09B 2.06B 137B 2.09B 14.05B 5.45B 67.62B 5.44B 5.32B 236B
Net Debt 15.95B 13.97B 12.89B 12.03B 22.66B 1,509B 23.06B 155B 60.03B 744B 59.94B 58.6B 2,593B 14.07B 12.32B 11.37B 10.61B 19.98B 1,331B 20.34B 136B 52.95B 657B 52.87B 51.69B 2,287B
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical management systems (52.4%): medication delivery systems, pharmaceutical systems, advanced patient monitoring systems, etc.; - interventional medical equipment (23.9%): surgical instruments, urological care products, etc.; - diagnostic materials and clinical research and development tools (23.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, tools for studying genes and culturing cells, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (58.6%), Europe/Middle East/Africa (21.6%), Asia (14.2%) and other (5.6%).
Employees
72,000
Date Price Change Volume
01/07/26 USD 151.33 -2.49% 2,055,881
29/06/26 USD 155.19 -0.47% 2,396,596
26/06/26 USD 155.92 +3.00% 12,180,748
25/06/26 USD 151.38 +2.44% 2,548,949
24/06/26 USD 147.77 +2.68% 2,300,230
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
14
Last Close Price
155.19USD
Average target price
177.75USD
Spread / Average Target
+14.54%

Quarterly revenue - Rate of surprise